Molecular diagnosis of chronic granulomatous disease

Manual of Molecular and Clinical Laboratory Immunology: 7th edition

Volumn , Issue , 2022, Pages 262-271

  Heyworth, Paul G ^a   Curnutte, John T ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Chronic granulomatous disease (CGD); Genetic analysis; Genomic DNAMutations; Prenatal diagnosis; Single strand conformational polymorphism (SSCP) analysis

Indexed keywords

EID: 84898981212     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1128/9781555815905.ch30     Document Type: Chapter

References (21)

1. Clark, R. A., H. L. Malech, J. I. Gallin, H. Nunoi, B. D. Volpp, D. W. Pearson, W. M. Nauseef, and J. T. Curnutte. 1989. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two discrete cytosolic components of the NADPH oxidase system. N. Engl.J. Med. 321:647-652.
2. Cross, A. R., F. K. Higson, O. T. G. Jones, A. M. Harper, and A. W. Segal. 1982. The enzymic reduction and kinetics of oxidation of the cytochrome b-245 of neutrophils. Biochem. J. 204:479-485.
3. +) with partially functional cytochrome b. J. Biol. Chem. 270:8194-8200.
4. Cross, A. R., D. Noack, J. Rae, J. T. Curnutte, and P. G. Heyworth. 2000. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (first update). Blood Cells Mol. Dis. 26:561-565.
5. Curnutte, J. T., R. Kuver, and P. J. Scott. 1987. Activation of neutrophil NADPH oxidase in a cell-free system: partial purification of components and characterization of the activation process. J. Biol. Chem. 262:5563-5569.
6. Heyworth, P. G., J. T. Curnutte, and J. A. Badwey. 1999. Structure and regulation of the NADPH oxidase of phagocytic leukocytes: insights from chronic granulomatous disease, p. 165-191. In C. N. Serhan and E A. Ward (ed.), Molecular and Cellular Basis of Inflammation. Humana Press Inc., Totowa, N.J.
7. Heyworth, P. G., J. T. Curnutte, J. Rae, D. Noack, D. Roos, E. van Koppen, and A. R. Cross. 2001. Hematologically important mutations: X-linked chronic granulomatous disease-second update. Blood Cells Mol. Dis. 27:16-26.
8. 0 chronic granulomatous disease carrier detection. Blood 100:1845-1851.
9. Heyworth, P. G., A. R. Cross, and J. T. Curnutte. 2003. Chronic granulomatous disease. Curr. Opin. Immunol. 15:578-584.
10. Noack, D., J. Rae, A. R. Cross, J. Munoz, S. Salmen, J. A. Mendoza, N. Rossi, J. T. Curnutte, and P. G. Heyworth. 1999. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte oxidase. Hum. Genet. 105:460-467.
11. Noack, D., J. Rae, A. R. Cross, B. A. Ellis, P. E. Newburger, J. T. Curnutte, and P. G. Heyworth. 2001. Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47- phox: mutations not arising in the NCF-1 pseudogenes. Blood 97:305-311.
12. Parkos, C. A., M. C. Dinauer, A. J. Jesaitis, S. H. Orkin, and J. T. Curnutte. 1989. Absence of both the 91 kD and 22 kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. Blood 73:1416-1420.
13. Patiño, P. J., J. Rae, D. Noack, R. W. Erickson, J. Ding, D. Garcia de Olarte, and J. T. Curnutte. 1999. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the NADPH oxidase component p67-phox. Blood 94:2505-2514.
14. Rae, J., P. E. Newburger, M. C. Dinauer, D. Noack, P J. Hopkins, R. Kuruto, and J. T. Curnutte. 1998. X-linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory- burst oxidase. Am. J. Hum. Genet. 62:1320-1331.
15. Rae, J., D. Noack, P. G. Heyworth, B. A. Ellis, J. T. Curnutte, and A. R. Cross. 2000. Molecular analysis of nine new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22-phox. Blood 96:1106-1112.
16. Roesler, J., J. T. Curnutte, J. Rae, D. Barrett, P. Patiño, S. J. Chanock, and A. Görlach. 2000. Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease. Blood 95:2150-2156.
17. Roos, D., and J. T. Curnutte. 1999. Chronic granulomatous disease, p. 353-374. In H. D. Ochs, C. I. E. Smith, and J. M. Puck (ed.), Primary Immunodeficiency Diseases: a Molecular and Genetic Approach. Oxford University Press, New York, N.Y.
18. Roos, D., M. De Boer, F. Kuribayashi, C. Meischl, R. S. Weening, A. W. Segal, A. Åhlin, K. Nemet, J. P. Hossle, E. Bernatowska-Matuszkiewicz, and H. Middleton-Price. 1996. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87:1663-1681.
19. Segal, B. H., T. L. Leto, J. I. Gallin, H. L. Malech, and S. M. Holland. 2000. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79:170-200.
20. Vignais, P. V. 2002. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell. Mol. Life Sci. 59:1428-1459.
21. Winkelstein, J. A., M. C. Marino, R. B. Johnston, Jr., J. Boyle, J. Curnutte, J. I. Gallin, H. L. Malech, S. M. Holland, H. Ochs, P. Quie, R. H. Buckley, C. B. Foster, S. J. Chanock, and H. Dickler. 2000. Chronic granulomatous disease-report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169.